TRIM29 and esophageal adenocarcinoma: The results showed that TRIM29 expression in precancerous lesions of ESCA, including Barrett’s esophagus (BE) and dysplasia, was significantly lower than in matched adjacent/normal esophageal epithelial tissues (Fig. 2C–H).